Stay updated on Avelumab First-line NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avelumab First-line NSCLC Clinical Trial page.

Latest updates to the Avelumab First-line NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history. The government-funding operating-status notice was removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding lapse notice was added, and the page revision updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedUI updates add a glossary display option, color-coded highlights for additions (green) and deletions (red), and an updated revision tag (v3.4.0) on the Record History page.SummaryDifference0.6%

- Check42 days agoChange DetectedRevision v3.3.4 is now listed in the Record History, replacing the prior v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history page now shows a new Revision: v3.3.3 entry, and the footer items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe Record History page shows a new revision label v3.3.2 and removes v3.2.0. This appears to be a minor interface update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Avelumab First-line NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab First-line NSCLC Clinical Trial page.